
Veeva Systems (VEEV) Stock Forecast & Price Target
Veeva Systems (VEEV) Analyst Ratings
Bulls say
Veeva Systems is poised for continued growth due to strong performance in their CRM and subscription segments and increased migration to Vault CRM. The introduction of their new AI solution, Falcon, is expected to drive additional growth and the company's focus on winning back customers and expanding their software offerings in the biopharma industry show potential for future success. Despite anticipating decelerated growth in the 4th quarter, Veeva remains confident in their execution and the potential for monetization of their AI products.
Bears say
Veeva Systems is a leading provider of cloud-based software solutions for the life sciences industry, but its limited flexibility and increasing competition in the pharma CRM space could lead to slower growth and lower margins in the future. While the company has posted strong results in the past, its high valuation of 20x CY28 EBITDA raises concerns about its ability to maintain its market leader position and may lead to downside risks for investors. Additionally, the company's concentration of top-20 pharma customers and uncertain monetization of its AI technology add further uncertainty to its future growth prospects.
This aggregate rating is based on analysts' research of Veeva Systems and is not a guaranteed prediction by Public.com or investment advice.
Veeva Systems (VEEV) Analyst Forecast & Price Prediction
Start investing in Veeva Systems (VEEV)
Order type
Buy in
Order amount
Est. shares
0 shares